Centre for Personalised Molecular Immunotherapy (Q3298146): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in fr, and other parts: Adding French translations)
(‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations)
label / nllabel / nl
 
Centrum voor gepersonaliseerde Moleculaire Immunotherapie
Property / summary
 
Nauwe samenwerking met partners uit de industrie om nieuwe efficiënte antilichamen en tumortherapieën te ontwikkelen. (Dutch)
Property / summary: Nauwe samenwerking met partners uit de industrie om nieuwe efficiënte antilichamen en tumortherapieën te ontwikkelen. (Dutch) / rank
 
Normal rank
Property / summary: Nauwe samenwerking met partners uit de industrie om nieuwe efficiënte antilichamen en tumortherapieën te ontwikkelen. (Dutch) / qualifier
 
point in time: 19 December 2021
Timestamp+2021-12-19T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 10:25, 19 December 2021

Project Q3298146 in Germany
Language Label Description Also known as
English
Centre for Personalised Molecular Immunotherapy
Project Q3298146 in Germany

    Statements

    country
    Germany
    0 references
    budget
    5,037,747.0 Euro
    0 references
    start time
    18 October 2016
    0 references
    end time
    31 October 2021
    0 references
    beneficiary name (string)
    Universität Würzburg
    0 references
    beneficiary
    Q3358400
    0 references
    programme
    Bayern - ERDF
    0 references
    coordinate location

    50°1'21.29"N, 9°53'30.62"E
    0 references
    summary
    Enge Kooperation mti Industriepartnern zur Entwicklung neuer effizienter Antikörper und Tumortherapien. (German)
    0 references
    Close cooperation with industry partners to develop new efficient antibodies and tumor therapies. (English)
    point in time
    24 October 2021
    0 references
    Coopération étroite avec les partenaires industriels pour le développement de nouveaux anticorps efficaces et thérapies tumorales. (French)
    point in time
    6 December 2021
    0 references
    Nauwe samenwerking met partners uit de industrie om nieuwe efficiënte antilichamen en tumortherapieën te ontwikkelen. (Dutch)
    point in time
    19 December 2021
    0 references
    location (string)
    Unterfranken
    0 references

    Identifiers

    German Kohesio ID
    DE_TEMPORARY_944
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q3298146&oldid=20315028"